We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-44.86%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$1.34M
AUM Growth
-$119K
Cap. Flow
+$781K
Cap. Flow %
58.14%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CSTL icon
Castle Biosciences
CSTL
+$781K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$1.02B
$738K 54.91%
+33,626
New +$781K
WHWK
2
Whitehawk Therapeutics
WHWK
$263M
$329K 24.48%
26,666
– –
SYBX
3
DELISTED
Synlogic
SYBX
$237K 17.63%
13,727
– –
ACGN
4
DELISTED
Aceragen Inc
ACGN
$26K 1.93%
3,312
– –
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$8K 0.6%
1,834
– –
GNCA
6
DELISTED
Genocea Biosciences, Inc.
GNCA
$6K 0.45%
375,000
– –

Similar funds

FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return
FFGM
Founders Fund Growth Management San Francisco, California $7.04M AUM 82.06% 1-Year Est. Return

ABG Innovation Capital Partners III's Q2 2022 Portfolio in Review

As of Q2 2022, ABG Innovation Capital Partners III held 6 positions worth $1.34M, down 8.1% from $1.46M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III deployed $781K of net new capital in Q2 2022, opening 1 new position. Its largest new stake was Castle Biosciences: 33,626 shares worth $738K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III's largest Q2 2022 buy was Castle Biosciences: 33,626 shares worth $738K.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $1.34M portfolio in Q2 2022.
  • ABG Innovation Capital Partners III opened 1 new position and closed 0 in Q2 2022.
  • ABG Innovation Capital Partners III's portfolio value fell 8.1% quarter-over-quarter to $1.34M.

Based on ABG Innovation Capital Partners III's 13F filing for Q2 2022, filed 15 Aug 2022.